Pemeriksaan Diagnostik COVID-19 : Studi Literatur

Halmar, Halbina Famung; Febrianti, Nur; Kada, Maria Kurnyata Rante

doi:10.30651/jkm.v5i1.4758

Cited by 4 publications

(4 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The COVID-19 antigen rapid test was initially only used for initial screening and was eventually declared to be used as a diagnostic method. 7,15 This is undoubtedly related to the accuracy of the examination based on many studies where the sensitivity and specificity of the rapid antigen test were reported to be relatively high. as written by Chaimayo et al, based on their research results, the sensitivity and specificity of the COVID-19 rapid test antigen reached 98.33% and 98.73%.…”

Section: Discussionmentioning

confidence: 99%

Fenomena Gejala Pilek paling Sering pada Pasien COVID-19

Muharaam

Samara

2023

J Biomedika dan Kesehat

View full text Add to dashboard Cite

Latar BelakangCOVID-19 adalah penyakit menular yang diakibatkan oleh SARS-CoV-2 coronavirus baru yang belum pernah teridentifikasi pada manusia yang menimbulkan berbagai macam gejala. Gejala COVID-19 yang cukup sering ditemukan adalah batuk, pilek, demam. Rapid Test Antigen merupakan pemeriksaan dengan sensitivitas dan spesivisitas yang cukup tinggi sehingga sering digunakan untuk deteksi COVID-19. Penelitian ini bertujuan untuk mengetahui hubungan gejala batuk, pilek, dan demam dengan hasil reaktif pada pemeriksaan rapid test antigen COVID-19. Metode Penelitian ini menggunakan design cross-sectional menggunakan data rekam medis. Variabel yang dinilai berupa batuk, pilek, demam, dan hasil pemeriksaan rapid test antigen COVID-19. Analisis data menggunakan uji statistik chi-square dan regresi logistik dengan tingkat kemaknaan p<0.05. HasilKarakteristik subjek dominan berusia 31-45 tahun dan berjenis kelamin perempuan. Subjek bergejala batuk (88.2%), demam (80%), dan pilek (60%%). Hasil pemeriksaan rapid test antigen COVID-19 ditemukan lebih banyak yang reaktif (80%). Distribusi hasil reaktif rapid test antigen COVID-19 adalah 86.7% pada batuk, 92.2% pada pilek, dan 91.2% pada demam. Terdapat hubungan bermakna antara batuk (p=0,000), pilek (p=0,001), dan demam (p=0,000) dengan hasil reaktif pemeriksaan rapid testantigen COVID-19. Pasien dengan gejala pilek memiliki risiko 8.67 kali lebih besar terjadinya reaktif pemeriksaan rapid test antigen COVID-19. KesimpulanTerdapat hubungan antara gejala batuk, pilek, dan demam dengan hasil reaktif pada pasien berusia 17 tahun ke atas. Keluhan pilek memiliki risiko lebih tinggi terjadinya hasil reaktif pada pemeriksaan rapid test antigen COVID-19 dibandingkan batuk dan demam. Oleh karena itu pasien dengan keluhan pilek perlu lebih mewaspadai kemungkinan terinfeksi COVID-19.

show abstract

Section: Discussionmentioning

confidence: 99%

Fenomena Gejala Pilek paling Sering pada Pasien COVID-19

Muharaam

Samara

2023

J Biomedika dan Kesehat

View full text Add to dashboard Cite

show abstract

“…Patients who will undergo elective and cito caesarean section and inpartum must be screened according to the flow for obstetric patients (5). However, with the limited facilities and infrastructure at Bangli General Hospital and in Indonesia, adjustments are made by combining the flow with the Indonesian Ministry of Health guidelines and recommendations from the COVID-19 Accelerated Handling Task Force (7,8). In accordance with the recommendations of the COVID-19 Accelerated Handling Task Force, rapid tests must be carried out on pregnant women before giving birth, except for referral cases where rapid tests have been carried out or pregnant women who have confirmed COVID-19.…”

Section: Discussionmentioning

confidence: 99%

Development of Caesarean Section Clinical Pathway: A Lesson Learned

Sastrawan¹,

Wardhani²

2022

JKB

View full text Add to dashboard Cite

Although clinical pathway (CP) is aimed to ensure quality and cost, the development of CP at hospitals is primarily for administrative purposes as it is required by accreditation standards, thus causing high variations in its implementation. This study aimed to develop a clinical pathway for caesarean section and explore the problem during development and implementation test. The selection of caesarean section was based on high volume, risk, and cost. Using participatory action research, the researcher started the program by performing an implementation evaluation, literature review, and regulatory development. The evaluation identified implementation discrepancies and prolonged length of stay. Based on the evaluation and literature review results, the Professional Care Provider (PCP) in the hospital conducted discussions and made suggestions by considering available resources, current practices, and behavior. The main differences of the new clinical pathway are: 1) it is developed based on literature and current practice, and 2) it should be added with notification, explanation, inclusion and exclusion criteria, and references. Before the implementation test, the hospital provide resources, develops a standard operational procedure followed by monitoring and evaluation. Differences in the type of medication and documentation method were found, which then further discussed with all involved PCP to define the agreed solutions. Professional engagement and openness culture that embraces along the process are the main key lesson learned in addition to the understanding that CP development and implementation is a continuous learning process.

show abstract

“…This article identifies the COVID-19 detection checks that several countries have carried out. This study concludes that an accurate and precise COVID-19 detection test must combine Real-Time Polymerase Chain Reaction (RT-PCR), Computed Tomography (CT)-Chest, and Rapid Test (Halmar et al, 2020).…”

Section: Literature Reviewmentioning

confidence: 93%

From Nationalization to Securitization: An Analysis of the Use of Genose Covid-19 Test Kits in Indonesia

Fathoni Hakim

2022

SARPASS

View full text Add to dashboard Cite

This research was carried out starting from the contemplation of seeing the Indonesian Government Policy on handling COVID-19 which is often inconsistent in several ways. The consequence of these problems is the trend of an increase in the number of Indonesian people who were confirmed positive for COVID-19. One of the inconsistencies in Indonesian government Policy can be seen in using the GeNose C-19 as a legally used COVID-19 test kit in Indonesia. GeNose developed and produced by Gadjah Mada University is claimed to be the national product. The procedure of GeNose is different from Polymerase Chain Reaction (PCR) and Swab tests. GeNose uses a breathing technique, and its result can be seen in 80 seconds. Aside from that, GeNose is also relatively cheap in terms of cost, when compared to PCR tests and Swab tests. It was designated as an official COVID-19 test kit in early 2021 by the state and has officially started being used legally at various airports, stations, and bus terminals. But unfortunately, in the last few days, due to an increase in the number of Indonesians who are confirmed positive for COVID-19, GeNose has started to stop. Hence, this research will look at the dynamics of how the Indonesian government is carrying out the nationalization and securitization of the GeNose test kit The researcher uses Barry Buzan's securitization theory and public health policy approach as analytical tools. The research method used is a qualitative approach with content analysis techniques. The results of the study stated that the actor of the nationalization and securitization of the GeNose issue was the state. There is a shifting paradigm in threats from military security to human security. GeNose issue so that at first nationalized and then constructed into a security threat and carried out securitization.

show abstract

Pemeriksaan Diagnostik COVID-19 : Studi Literatur

Cited by 4 publications

References 12 publications

Fenomena Gejala Pilek paling Sering pada Pasien COVID-19

Fenomena Gejala Pilek paling Sering pada Pasien COVID-19

Development of Caesarean Section Clinical Pathway: A Lesson Learned

From Nationalization to Securitization: An Analysis of the Use of Genose Covid-19 Test Kits in Indonesia

Contact Info

Product

Resources

About